Actions and Detail Panel
Future of Precision Medicine Forum
Wed 19 April 2017, 6:00 PM – 8:00 PM Singapore Standard Time Singapore Time
Join us as we bring together industry veterans – a renowned scientist (A*STAR), a highly-acclaimed researcher (Genome Institute of Singapore) and a serial entrepreneur in this exciting discussion on where Precision Medicine is heading, the opportunities and challenges that Precision Medicine players face.
Precision Medicine is the ultimate personalisation of healthcare. Transforming the field of medicine and accelerating biomedical discoveries, Precision Medicine is enabling a perfectly tailored treatment based on individual precision diagnostics of each person’s unique genetic makeup – your DNA.
The promise of Precision Medicine is not only an inspiration to patients in their approach for personalised healthcare, it is also a huge opportunity for forward-thinking organisations, namely the technology companies. Data is a key driver in the precision medicine movement, and is instrumental in driving collaboration among the key technology players needed across the industry.
In order to reach the full potential of Precision Medicine, and make personalised medicine a new standard of healthcare, this will require a shift in current thinking and collaboration among other multiple players - the providers, researchers, patients, pharmaceutical companies and regulators.
Precision Medicine Enabling Accurate Diagnosis and Treatment of Cancer
Prof. Sir David LANE, Chief Scientist, A*STAR
How Technologies will Change Medicine?
Prof. NG Huck Hui, Executive Director, Genome Institute of Singapore
Commercially Viable "Little Data" and Precision Medicine Successes
Ravinder SAJWAN, Chief Executive Officer and Board Member, Renew Group Private Limited
Panel Discussion: Opportunities & Challenges Precision Medicine Players Face
Moderated by Steve Leonard, Founding CEO, SGInnovate
Panelists: Prof. Sir David Lane, Prof. Ng Huck Hui, Ravinder Sajwan